Search
for
Sort by
Research 241–270 of 246
- Subject Index
- Author Index
- ZALCITABINE
- TACRINE
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Importancia de la pseudopelada de Brocq en la práctica de la medicina estética capilar
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Cutaneous Manifestations of Lupus Erythematosus
- The Itchy Scalp
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Dermatologic therapy: December 1987 to December 1988
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Drug repurposing: Clinical practices and regulatory pathways
- Mast Cells and Scarring Alopecia: Is There a Clear Pathophysiological Relationship?
- Drug repositioning using <i>in silico</i> compound profiling
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Cutaneous drug reactions
- Benign Cutaneous Eruptions After Transplantation
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- An Overview of Alopecias
- Update on the dermatologic use of systemic glucocorticosteroids
- Secondary cicatricial and other permanent alopecias
- Acne and acneiform eruptions